58 related articles for article (PubMed ID: 11762032)
1. [Genetic control of hepatocarcinogenesis in mice].
Lee GH
Nihon Rinsho; 2001 Oct; 59 Suppl 6():66-70. PubMed ID: 11762032
[No Abstract] [Full Text] [Related]
2. Genetic control of hepatocarcinogenesis in C3H mice.
Drinkwater NR
Drug Metab Rev; 1994; 26(1-2):201-8. PubMed ID: 8082565
[No Abstract] [Full Text] [Related]
3. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.
Manenti G; Binelli G; Gariboldi M; Canzian F; De Gregorio L; Falvella FS; Dragani TA; Pierotti MA
Genomics; 1994 Sep; 23(1):118-24. PubMed ID: 7829059
[TBL] [Abstract][Full Text] [Related]
4. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
Vorce RL; Goodman JI
J Toxicol Environ Health; 1991 Nov; 34(3):385-95. PubMed ID: 1942124
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
[TBL] [Abstract][Full Text] [Related]
6. Mouse strain susceptibility to diethylnitrosamine induced hepatocarcinogenesis is cell autonomous whereas sex-susceptibility Is due to the micro-environment: analysis with C3H <--> BALB / c sexually chimeric mice.
Tsukamoto T; Inada K; Fukami H; Yamamoto M; Tanaka H; Kusakabe M; Bishop CE; Tatematsu M
Jpn J Cancer Res; 2000 Jul; 91(7):665-73. PubMed ID: 10920272
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic promotion of murine hepatocarcinogenesis.
Drinkwater NR; Hanigan MH; Kemp CJ
Prog Clin Biol Res; 1990; 331():163-76. PubMed ID: 2156269
[No Abstract] [Full Text] [Related]
8. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Calvisi DF; Virdis P; Bosinco GM; Frau M; Seddaiu MA; Ladu S; Feo F
Cancer Res; 2002 Aug; 62(15):4459-63. PubMed ID: 12154055
[TBL] [Abstract][Full Text] [Related]
9. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BL/6N chimeric mice.
Lee GH; Nomura K; Kanda H; Kusakabe M; Yoshiki A; Sakakura T; Kitagawa T
Cancer Res; 1991 Jun; 51(12):3257-60. PubMed ID: 2040001
[TBL] [Abstract][Full Text] [Related]
10. The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility.
Bugni JM; Poole TM; Drinkwater NR
Carcinogenesis; 2001 Nov; 22(11):1853-62. PubMed ID: 11698349
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
[TBL] [Abstract][Full Text] [Related]
12. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
[TBL] [Abstract][Full Text] [Related]
13. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes.
Dragani TA; Manenti G; Della Porta G
J Cancer Res Clin Oncol; 1987; 113(3):223-9. PubMed ID: 3584213
[TBL] [Abstract][Full Text] [Related]
15. C57BR/cdJ hepatocarcinogen susceptibility genes act cell-autonomously in C57BR/cdJ<-->C57BL/6J chimeras.
Chiaverotti TA; Drinkwater NR
Cancer Res; 2003 Aug; 63(16):4914-9. PubMed ID: 12941815
[TBL] [Abstract][Full Text] [Related]
16. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of multistage hepatocarcinogenesis.
Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
[No Abstract] [Full Text] [Related]
18. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
Phillips JM; Yamamoto Y; Negishi M; Maronpot RR; Goodman JI
Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
[TBL] [Abstract][Full Text] [Related]
19. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
[TBL] [Abstract][Full Text] [Related]
20. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease.
Tabibiazar R; Wagner RA; Spin JM; Ashley EA; Narasimhan B; Rubin EM; Efron B; Tsao PS; Tibshirani R; Quertermous T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):302-8. PubMed ID: 15550693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
